BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38480756)

  • 1. Preclinical systolic dysfunction relating to ankle-brachial index among high-risk PAD population with preserved left ventricular ejection fraction.
    Lin YH; Sung KT; Tsai CT; Lai YH; Lo CI; Yu FC; Lan WR; Hung TC; Kuo JY; Hou CJ; Yen CH; Peng MC; Yeh HI; Wu MT; Hung CL
    Sci Rep; 2024 Mar; 14(1):6145. PubMed ID: 38480756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.
    Prasada S; Shah SJ; Michos ED; Polak JF; Greenland P
    Vasc Med; 2019 Dec; 24(6):501-510. PubMed ID: 31480898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layer-specific strain in patients with heart failure using cardiovascular magnetic resonance: not all layers are the same.
    Xu L; Pagano JJ; Haykowksy MJ; Ezekowitz JA; Oudit GY; Mikami Y; Howarth A; White JA; Dyck JRB; Anderson T; Paterson DI; Thompson RB;
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):81. PubMed ID: 33267877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
    Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
    Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.
    Hensen LCR; Goossens K; Delgado V; Abou R; Rotmans JI; Jukema JW; Bax JJ
    Eur J Heart Fail; 2018 Mar; 20(3):560-568. PubMed ID: 29164753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of brachial-ankle pulse-wave velocity in patients with heart failure with preserved left ventricular ejection fraction.
    Tokitsu T; Yamamoto E; Oike F; Hirata Y; Tsujita K; Yamamuro M; Kaikita K; Hokimoto S
    J Hypertens; 2018 Mar; 36(3):560-568. PubMed ID: 29084082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction.
    Brann A; Miller J; Eshraghian E; Park JJ; Greenberg B
    Eur J Heart Fail; 2023 Oct; 25(10):1755-1765. PubMed ID: 37369633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction: correlation of global longitudinal strain with invasive diastolic functional indices.
    Ito H; Ishida M; Makino W; Goto Y; Ichikawa Y; Kitagawa K; Omori T; Dohi K; Ito M; Sakuma H
    J Cardiovasc Magn Reson; 2020 Jun; 22(1):42. PubMed ID: 32498688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal, circumferential and radial systolic left ventricular function in patients with heart failure and preserved ejection fraction.
    Gregorova Z; Meluzin J; Stepanova R; Sitar J; Podrouzkova H; Spinarova L
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):385-92. PubMed ID: 26948032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of peripheral artery disease on left ventricular diastolic function.
    Yanaka K; Akahori H; Imanaka T; Miki K; Yoshihara N; Tanaka T; Asakura M; Masuyama T; Ishihara M
    J Cardiol; 2019 Jun; 73(6):453-458. PubMed ID: 30792034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and prognosis of patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction.
    Chen QF; Hu J; Hu J; Nijjar PS; Xu J; Shi S; Liang D; Liao H; Gao J; Lin WH; You S; Zhou XD
    Clin Res Cardiol; 2024 May; 113(5):761-769. PubMed ID: 38197895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.
    Vasan RS; Xanthakis V; Lyass A; Andersson C; Tsao C; Cheng S; Aragam J; Benjamin EJ; Larson MG
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):1-11. PubMed ID: 28917679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.